CWM
IOVA icon

Centurion Wealth Management’s Iovance Biotherapeutics IOVA Stock Holding History

Centurion Wealth Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288K Buy
69,168
+10,784
+18% +$41K 0.07% 229
2026
Q1 		$205K Buy
58,384
+6,000
+11% +$19.2K 0.05% 297
2025
Q4 		$143K Sell
52,384
-700
-1% -$1.62K 0.03% 301
2025
Q3 		$115K Buy
+53,084
New +$125K 0.03% 299

Other funds holding IOVA

MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Centurion Wealth Management's IOVA Position: Q2 2026 in Review

Centurion Wealth Management increased its Iovance Biotherapeutics (IOVA) stake by 18% in Q2 2026, buying an estimated $41K and bringing the position to 69,168 shares worth $288K. The position accounts for 0.07% of the portfolio, ranked #229.

Centurion Wealth Management first reported a position in IOVA in Q3 2025 and has held it in 4 quarters since. 19 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Centurion Wealth Management held 69,168 shares of Iovance Biotherapeutics worth $288K as of Q2 2026.
  • Centurion Wealth Management bought 10,784 Iovance Biotherapeutics shares in Q2 2026, an estimated $41K.
  • Iovance Biotherapeutics made up 0.07% of Centurion Wealth Management's portfolio in Q2 2026, its #229 holding.
  • Centurion Wealth Management first reported a position in Iovance Biotherapeutics in Q3 2025 and has held it in 4 quarters since.
  • 19 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Centurion Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.